APDN: חוב להון עצמי adnas.com

Applied DNA Sciences (APDN) specializes in resource authenticity verification via DNA tagging and the contract manufacturing of biocomponents. This chart of market quotes demonstrates a debt-to-equity ratio of 0.05. While patent protection creates a technological barrier, slow adoption of molecular tracking limits growth. Meanwhile, steady demand for healthcare offsets geopolitical risks associated with sanctions pressure on supplies.

This ratio measures the degree of financial leverage by comparing total borrowed funds against net asset value to assess the stability of the balance sheet structure. By analyzing the total liabilities-to-equity chart, an investor can determine the deleveraging pace of Applied DNA Sciences (APDN), which is critical for a company whose demand within the US compliance control sector provides a stable foundation for business development.